| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
RZLT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 605.5K | $3.02M | - | |
| CFO | 395.4K | - | - | |
| Other | 293.9K | $1.47M | - | |
| ? | 170.9K | - | - | |
| ? | 119.7K | $202.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Kreher Nerissa54 | - | Buy | 3,076 | $3.25 | $9,997.00 | +8.9% | +89.8% | -4.8% | |
| Mar 31, 2025 | Hogenhuis Wladimir47 | - | Buy | 6,758 | $2.92 | $19,733.36 | +8.7% | +53.8% | +5.2% | |
| Mar 27, 2025 | Elam Nevan C76 | CEO | Buy | 12,302 | $2.85 | $34,999.19 | +5.8% | +48.3% | +2.4% | |
| Mar 26, 2025 | Evans Daron81 | CFO | Buy | 20,000 | $2.89 | $57,700.00 | +666.7% | +55.3% | +19.0% | |
| Feb 18, 2025 | Hogenhuis Wladimir47 | - | Buy | 10,000 | $4.70 | $47,000.00 | +14.9% | -20.3% | -24.2% | |
| Dec 18, 2024 | Evans Daron81 | CFO | Buy | 10,000 | $4.29 | $42,900.00 | +7.1% | -17.4% | -54.7% | |
| Dec 12, 2024 | Evans Daron81 | CFO | Buy | 9,000 | $4.60 | $41,400.00 | +6.8% | -19.0% | -61.2% | |
| Sep 24, 2024 | Hogenhuis Wladimir47 | - | Buy | 4,259 | $4.70 | $20,017.30 | +11.4% | -5.3% | +87.8% | |
| Jun 25, 2024 | Kim Young-Jin52 | - | Buy | 1,250,000 | $4.00 | $5,000,000.00 | +21.0% | +23.8% | +11.9% | |
| Jun 25, 2024 | Hogenhuis Wladimir47 | - | Buy | 4,815 | $4.15 | $19,982.25 | +14.7% | +23.8% | +11.9% |